| 规格 | 10ug |
|---|---|
| 表达宿主 | E.coli |
| 标签 | NA |
| 分子量 | 18.1 KDa |
|---|---|
| 表观分子量 | 18 KDa, reducing conditions |
| 形态 | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
| 纯度 | Greater than 95% as determined by reducing SDS-PAGE. |
| 内毒素水平 | Less than 0.001 ng/µg (0.01 EU/µg) as determined by LAL test. |
|---|---|
| 活性 | Immobilized Mouse ST2-His(Cat#CK89) at 5μg/ml (100 μl/well) can bind Human IL-33(Cat#C091).The ED50 of Human IL-33(Cat#C091) is 0.63 ug/ml. |
| 溶解方法 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
|---|---|
| 储存方法 | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
| 背景说明 | Interleukin-33 (IL-33) was initially discovered as a nuclear factor NF-HEV abundantly expressed in high endothelial venules. It is a 30-32 kD pro-inflammatory protein with intracellular and extracellular activities and a chromatin-associated cytokine of the IL-1 family with high sequence and structural similarity to IL-1 and IL-18. IL-33 is highly and selectively expressed by high endothelial venule endothelial cells (HEVECs) in human tonsils, Peyers's patches, and lymph nodes. It contains a bipartite nuclear localization signal at the C-terminus, and is targeted to the nucleus when ectopically expressed in human umbilical vein endothelial cells (HUVECs) and HeLa cells. The C-terminal fragment, corresponding to mature IL-33, binds and triggers signaling. IL-33 mediates its biological effects via Toll-interleukin 1 (IL-1) receptor (TIR) domain-containing receptor ST2, activates NF-kappaB and MAP kinases, and drives production of T(H)2-associated cytokines from in vitro polarized T(H)2 cells. In vivo, IL-33 induces the expression of IL-4, IL-5, and IL-13 and leads to severe pathological changes in mucosal organs. Human IL-33 is 270 amino acids in length. |
|---|
| 产品名称 | 点击数 |
|---|---|
| 多粘菌素B(粘菌素)-BSA抗原 | 3822 |
| 莫能菌素-BSA(或OVA)抗原 | 3649 |
| 阿苯达唑-2-氨基砜-BSA(或OVA)抗原 | 3633 |
| 阿苯达唑砜-BSA(或OVA)抗原 | 3695 |
| 托灭酸(托芬那酸)-BSA(或OVA)抗原 | 3590 |
| 氟尼辛-BSA(或OVA)抗原 | 3667 |
| 卡洛芬-BSA(或OVA)抗原 | 3586 |
| 司坦唑醇-BSA(或OVA)抗原 | 3784 |
| 褪黑素-BSA(或OVA)抗原 | 3781 |
| 壬基酚-BSA(或OVA)抗原 | 3769 |
| 妥曲珠利-BSA(或OVA)抗原 | 3724 |
| 帕托珠利(妥曲珠利砜)-BSA(或OVA)抗原 | 3813 |
| 己烷雌酚-BSA(或OVA)抗原 | 3667 |
| 泰乐菌素-BSA(或OVA)抗原 | 3653 |
| 阿苯达唑-BSA(或OVA)抗原 | 3709 |
| 可乐定-BSA(或OVA)抗原 | 3702 |
| 甲砜霉素-BSA(或OVA)抗原 | 3847 |
| 苏丹红II-BSA(或OVA)抗原 | 3692 |
| 替米考星-BSA(或OVA)抗原 | 3740 |
| 达氟沙星-BSA(或OVA)抗原 | 3808 |